1. Market Research
  2. > Software Market Trends
  3. > Computational Medicine and Drug Discovery Software Market Analysis:By Tools (Software, Databases and Others); By Application (Drug Discovery and Development, Disease Modeling, Medical Imaging and Others) & By Geography - Forecast (2015 - 2020)

The computational medicine and drug discovery software market encompasses the use of pharmacy, chemistry, biotechnology and software knowledge for drug discovery and development. This is accompanied by development of algorithms and simulation of various models to study the pharmacokinetics and pharmacodynamics of a particular drug.

The global market for computational medicine and drug discovery software is valued at $X billion in 2014 and is projected to grow with a healthy double digit CAGR of XX% through 2020. Recent growth in disease modeling, drug designing and development by leveraging various bioinformatics tools will lead to the market growth during the period under study (2014-2020).

As of 2014, the application of computational medicine in simulation of cells is estimated to grow at the fastest pace, due to the increasing research activities on sequencing of proteins to design and develop customized medicines suited to an individual’s needs. Drug discovery, development and disease modeling applications occupy the highest market share owing to the widespread drug development approaches adopted by several major pharmaceutical companies.

The North America, led by the U.S. accounted for the largest market share in the global market for computational medicine and drug discovery software, occupying over 55% of the revenue in 2014. The huge market size can be credited to the increasing investments in R&D activities pertaining to drug discovery and development and disease modelling.

Table Of Contents

Computational Medicine and Drug Discovery Software Market Analysis:By Tools (Software, Databases and Others); By Application (Drug Discovery and Development, Disease Modeling, Medical Imaging and Others) and By Geography - Forecast (2015 - 2020)
1. Global Computational Medicine and Drug Discovery Software Market Overview
2. Executive Summary
3. Global Computational Medicine and Drug Discovery Software Market Landscape
3.1. Market share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End-User Profiling
3.2.3. Patent Analysis
3.2.4. Top 5 Financial Analysis
4. Global Computational Medicine and Drug Discovery Software - Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Attractiveness of the Industry
4.4.1. Power of Suppliers
4.4.2. Power of Customers
4.4.3. Threat of New entrants
4.4.4. Threat of Substitution
4.4.5. Degree of Competition
5. Global Computational Medicine and Drug Discovery Software Market - Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunity Analysis
5.4. Product Life Cycle Analysis
5.5. Suppliers and Distributors
6. Global Computational Medicine and Drug Discovery Software Market - By Tools
6.1. Introduction
6.2. Databases
6.3. Software
6.4. Others
7. Global Computational Medicine and Drug Discovery Software Market - By Application
7.1. Introduction
7.2. Computational Physiological Medicine
7.3. Drug Discovery and Development
7.4. Medical Imaging
7.5. Disease Modelling
7.6. Predictive Analysis of Drug Targets
7.7. Cellular Simulation
7.8. Simulation Software
7.9. Others
8. Global Computational Medicine and Drug Discovery Software Market - By Geography
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.3. Europe
8.3.1. U.K.
8.3.2. Germany
8.3.3. Netherlands
8.3.4. Norway
8.3.5. Italy
8.3.6. Others
8.4. APAC
8.4.1. China
8.4.2. Japan
8.4.3. Korea
8.4.4. Australia
8.4.5. Others
8.5. RoW
9. Market Entropy
9.1. New Product Launches
9.2. MandAs, Collaborations, Partnerships and JVs
10. Investment Opportunities
11. Company Profiles
11.1. Aurora Fine Chemicals LLC
11.2. Biognos AB
11.3. Certara, L.P.
11.4. Chemical Computing Group Inc.
11.5. CLC bio
11.6. Collaborative Drug Discovery, Inc.
11.7. Compugen Ltd.
11.8. Crown Bioscience Inc.
11.9. Dassault Systemes, BIOVIA Corp.
11.10. Domainex Ltd
11.11. Entelos, Inc.
11.12. Genedata AG
11.13. Leadscope, Inc.
11.14. Nimbus Therapeutics
11.15. Prosarix Ltd
11.16. Quant Med LLC
11.17. Quantum Pharmaceuticals
11.18. Rhenovia Pharma Limited
11.19. Simulations Plus, Inc.
11.20. Schrödinger, LLC
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
12. Appendix
12.1. Abbreviations
12.2. Sources
12.3. Research Methodology
12.4. Bibliography
12.5. Compilation of Expert Insights
12.6. Disclaimer

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Encryption Software Market by Application, Service, Deployment Type, User Type, Industry Vertical, Region - Global Forecast to 2021

Encryption Software Market by Application, Service, Deployment Type, User Type, Industry Vertical, Region - Global Forecast to 2021

  • $ 7150
  • Industry report
  • October 2016
  • by MarketsandMarkets

“Increasing need to safeguard data against cyber-attacks will drive the encryption software market” The encryption software market size is estimated to grow from USD 3.05 billion in 2016 to USD 8.94 ...

Mobile BI Market by Type (Software, Services), Business Function (IT, Finance, Sales, Marketing, Operations, HR), Business Application, Organization Size (SMES, Large Enterprises), Industry Vertical, and Region - Global Forecast to 2021

Mobile BI Market by Type (Software, Services), Business Function (IT, Finance, Sales, Marketing, Operations, HR), Business Application, Organization Size (SMES, Large Enterprises), Industry Vertical, and Region - Global Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

“Increasing BYOD trend is driving the growth” MarketsandMarkets estimates the global mobile Business Intelligence (BI) market to grow from USD 4.08 billion in 2016 to USD 11.13 billion by 2021, at ...

Clinical Decision Support Systems Market by Component, Delivery Mode, Product Type, Model, Type, User Interactivity, Application - Forecasts to 2021

Clinical Decision Support Systems Market by Component, Delivery Mode, Product Type, Model, Type, User Interactivity, Application - Forecasts to 2021

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The clinical decision support systems market is expected to reach USD 1,519.2 million by 2021 from USD 856.3 million in 2016, at a CAGR of 12.2% during the forecast period from 2016 to 2021. The government ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.